150 related articles for article (PubMed ID: 35641004)
1. Primary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma.
Smith ES; Jansen C; Miller KM; Chiang S; Alektiar KM; Hensley ML; Mueller JJ; Abu-Rustum NR; Leitao MM
Int J Gynecol Cancer; 2022 Jul; 32(7):882-890. PubMed ID: 35641004
[TBL] [Abstract][Full Text] [Related]
2. Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma?
Karataşlı V; Çakır İ; Can B; Erkılınç S; Karadeniz T; Kuru O; Gökçü M; Sancı M
J Obstet Gynaecol; 2021 Jul; 41(5):797-802. PubMed ID: 33063586
[TBL] [Abstract][Full Text] [Related]
3. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
5. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma.
Shah JP; Bryant CS; Kumar S; Ali-Fehmi R; Malone JM; Morris RT
Obstet Gynecol; 2008 Nov; 112(5):1102-8. PubMed ID: 18978112
[TBL] [Abstract][Full Text] [Related]
6. Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro): A Korean Multicenter Study.
Kim M; Choi C; Kim K; Lim MC; Park JY; Hong JH; Lee M; Paek J; Seoung J; Lee S; Lee TS
Int J Gynecol Cancer; 2018 Jul; 28(6):1123-1129. PubMed ID: 29664841
[TBL] [Abstract][Full Text] [Related]
7. Endometrial stromal sarcoma: treatment and patterns of recurrence.
Thomas MB; Keeney GL; Podratz KC; Dowdy SC
Int J Gynecol Cancer; 2009 Feb; 19(2):253-6. PubMed ID: 19396004
[TBL] [Abstract][Full Text] [Related]
8. Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database.
Nasioudis D; Mastroyannis SA; Latif NA; Ko EM; Haggerty AF; Kim SH; Morgan MA; Giuntoli RL
Surg Oncol; 2021 Sep; 38():101589. PubMed ID: 33957499
[TBL] [Abstract][Full Text] [Related]
9. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
[TBL] [Abstract][Full Text] [Related]
10. Endometrial stromal sarcoma: analysis of treatment failures and survival.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Urgesi A; Lissoni A; Losa G; Fanucchi A
Gynecol Oncol; 1996 Nov; 63(2):247-53. PubMed ID: 8910635
[TBL] [Abstract][Full Text] [Related]
11. Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review.
Signorelli M; Fruscio R; Dell'Anna T; Buda A; Giuliani D; Ceppi L; Milani R
Int J Gynecol Cancer; 2010 Nov; 20(8):1363-6. PubMed ID: 21051978
[TBL] [Abstract][Full Text] [Related]
12. Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma.
Amant F; De Knijf A; Van Calster B; Leunen K; Neven P; Berteloot P; Vergote I; Van Huffel S; Moerman P
Br J Cancer; 2007 Nov; 97(9):1194-9. PubMed ID: 17895898
[TBL] [Abstract][Full Text] [Related]
13. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.
Ørtoft G; Høgdall C; Hansen ES; Dueholm M
J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
[TBL] [Abstract][Full Text] [Related]
14. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
15. Is lymph node dissection mandatory among early stage endometrial cancer patients? A retrospective study.
Zhang G; Chen H; Liu Y; Niu L; Jin L; Li D; Song L; Shang L; Lin X; Wang F; Li F; Zhang X; Zhang X; Gao Y; Qiu D; Zhang Y; Na R; Su R
BMC Womens Health; 2020 Nov; 20(1):258. PubMed ID: 33213444
[TBL] [Abstract][Full Text] [Related]
16. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
[TBL] [Abstract][Full Text] [Related]
17. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
Weitmann HD; Kucera H; Knocke TH; Pötter R
Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
[TBL] [Abstract][Full Text] [Related]
18. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
[TBL] [Abstract][Full Text] [Related]
19. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study.
Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S
Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015
[TBL] [Abstract][Full Text] [Related]
20. Vaginal brachytherapy alone for patients with Stage II endometrial cancer with inner half cervical stromal invasion.
Barnes EA; Parra-Herran C; Martell K; Barbera L; Taggar A; Leung E
Brachytherapy; 2019; 18(5):606-611. PubMed ID: 31200993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
